|
Index of reports
> Cases with Pulmonary Oedema ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Letairis (Ambrisentan) where reactions include pulmonary oedema. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of Next >>
Possible Letairis side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: male
Reactions: Dyspnoea, Pulmonary Oedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Possible Letairis side effects in female
Reported by a physician from United States on 2012-08-21
Patient: female
Reactions: Pulmonary Vein Stenosis, Pulmonary Oedema, Unevaluable Event, Fluid Retention, Oxygen Saturation Decreased
Drug(s) suspected as cause:
Letairis
Indication: Heart Disease Congenital
Letairis
Dosage: 5 mg, unk
Administration route: Oral
Indication: Pulmonary Hypertension
Start date: 2012-06-11
Letairis
Dosage: 2.5 mg, unk
Administration route: Oral
Indication: Trisomy 21
Start date: 2012-06-28
Letairis
Indication: Sleep Apnoea Syndrome
Letairis
Indication: Pulmonary Vein Stenosis
Possible Letairis side effects in female
Reported by a physician from United States on 2012-08-20
Patient: female
Reactions: Pulmonary Oedema, Cardiac Disorder, Fluid Retention
Drug(s) suspected as cause:
Letairis
Possible Letairis side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-20
Patient: female
Reactions: Oedema Peripheral, Compression Fracture, Pulmonary Oedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Possible Letairis side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-15
Patient: male
Reactions: Dyspnoea, Pulmonary Oedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Possible Letairis side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-14
Patient: female
Reactions: Pulmonary Vein Stenosis, Pulmonary Oedema, Unevaluable Event, Oxygen Saturation Decreased, Fluid Retention
Drug(s) suspected as cause:
Letairis
Dosage: 5 mg, unk
Administration route: Oral
Indication: Pulmonary Hypertension
Start date: 2012-06-11
Letairis
Dosage: 2.5 mg, unk
Administration route: Oral
Indication: Trisomy 21
Start date: 2012-06-28
Letairis
Indication: Heart Disease Congenital
Letairis
Indication: Pulmonary Vein Stenosis
Letairis
Indication: Sleep Apnoea Syndrome
Possible Letairis side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-08
Patient: female
Reactions: Pulmonary Oedema, Fluid Retention, Oxygen Saturation Decreased
Drug(s) suspected as cause:
Letairis
Indication: Pulmonary Vein Stenosis
Letairis
Indication: Trisomy 21
Letairis
Indication: Sleep Apnoea Syndrome
Letairis
Indication: Heart Disease Congenital
Letairis
Dosage: 5 mg, unk
Administration route: Oral
Indication: Pulmonary Hypertension
Start date: 2012-06-11
Possible Letairis side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-02
Patient: female
Reactions: Anaemia, Pulmonary Oedema, Renal Failure Acute, Cardiorenal Syndrome
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Letairis
Other drugs received by patient: Alphagan P; Acetaminophen; Stalevo 100; Multi-Vitamins; Gabapentin; Cellcept; Pantoprazole Sodium; Prednisone; Tums / 00193601 /; Lantus; Metoclopramide Hydrochloride; Citalopram Hydrobromide; Prograf; Aspirin; Docusate Sodium; Humalog; Reglan; Magnesium Gluconate; Xalatan; Furosemide
Possible Letairis side effects in female
Reported by a physician from United States on 2012-08-02
Patient: female
Reactions: Pulmonary Oedema, Fluid Retention, Oxygen Saturation Decreased
Drug(s) suspected as cause:
Letairis
Indication: Heart Disease Congenital
Letairis
Indication: Pulmonary Vein Stenosis
Letairis
Dosage: 5 mg, unk
Administration route: Oral
Indication: Pulmonary Hypertension
Start date: 2012-06-11
Letairis
Indication: Trisomy 21
Letairis
Indication: Sleep Apnoea Syndrome
Possible Letairis side effects in female
Reported by a consumer/non-health professional from United States on 2012-07-19
Patient: female
Reactions: Compression Fracture, Pulmonary Oedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Possible Letairis side effects in female
Reported by a consumer/non-health professional from United States on 2012-07-17
Patient: female
Reactions: Pneumonia, Pulmonary Oedema, Unevaluable Event
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Possible Letairis side effects in female
Reported by a consumer/non-health professional from United States on 2012-06-29
Patient: female
Reactions: Anaemia, Pulmonary Oedema, Renal Failure Acute, Cardiorenal Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Possible Letairis side effects in female
Reported by a physician from United States on 2012-05-24
Patient: female
Reactions: Anaemia, Pulmonary Oedema, Renal Failure Acute, Cardiorenal Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Possible Letairis side effects in
Reported by a physician from United States on 2012-05-18
Patient:
Reactions: Pruritus, Dysphagia, Nausea, Oropharyngeal Pain, Headache, Flushing, Sensation of Foreign Body, Throat Irritation, Pulmonary Oedema
Drug(s) suspected as cause:
Letairis
Ventavis
Dosage: unk
Indication: Pulmonary Arterial Hypertension
Start date: 2012-04-12
Other drugs received by patient: Calcium Channel Blockers; ACE Inhibitors
Possible Letairis side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-07
Patient: female
Reactions: Coronary Artery Disease, Pulmonary Oedema
Drug(s) suspected as cause:
Letairis
Possible Letairis side effects in female
Reported by a consumer/non-health professional from United States on 2012-04-30
Patient: female
Reactions: Pulmonary Hypertension, COR Pulmonale Acute, Dyspnoea, Pulmonary Veno-Occlusive Disease, Pulmonary Oedema, Hypoxia, Respiratory Distress
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Indication: Diastolic Dysfunction
Letairis
Indication: Venoocclusive Disease
Letairis
Indication: Pulmonary Arterial Pressure Increased
Letairis
Dosage: 5 mg, unk
Administration route: Oral
Indication: Pulmonary Hypertension
Start date: 2012-02-22
Possible Letairis side effects in female
Reported by a consumer/non-health professional from United States on 2012-04-19
Patient: female
Reactions: Vomiting, Nausea, Chest Pain, Pulmonary Oedema, Unevaluable Event
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Possible Letairis side effects in female
Reported by a consumer/non-health professional from United States on 2012-04-17
Patient: female
Reactions: Renal Failure, Pulmonary Oedema, Cardiac Failure Congestive, Fluid Retention
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Possible Letairis side effects in male
Reported by a consumer/non-health professional from United States on 2012-04-04
Patient: male
Reactions: Pulmonary Oedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Possible Letairis side effects in female
Reported by a physician from United States on 2012-03-27
Patient: female
Reactions: Dyspnoea, Pulmonary Oedema, Pulmonary Arterial Hypertension, Pulmonary Function Test Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Dosage: 10 mg, unk
Administration route: Oral
Indication: Pulmonary Hypertension
Start date: 2011-03-20
Letairis
Dosage: unk
Administration route: Oral
Indication: Connective Tissue Disorder
Remodulin
Other drugs received by patient: Revatio
Possible Letairis side effects in female
Reported by a consumer/non-health professional from United States on 2012-03-23
Patient: female
Reactions: Dyspnoea, Pulmonary Oedema, Pulmonary Arterial Hypertension, Pulmonary Function Test Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Dosage: 10 mg, unk
Administration route: Oral
Indication: Pulmonary Hypertension
Start date: 2011-03-20
Letairis
Dosage: unk
Administration route: Oral
Indication: Connective Tissue Disorder
Other drugs received by patient: Remodulin; Revatio
Possible Letairis side effects in male
Reported by a physician from United States on 2012-03-21
Patient: male
Reactions: Dialysis, Pulmonary Oedema, Unevaluable Event
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Dosage: 5 mg, unk
Administration route: Oral
Indication: Pulmonary Hypertension
Start date: 2012-01-26
Letairis
Indication: Sleep Apnoea Syndrome
Letairis
Indication: Collagen-Vascular Disease
Possible Letairis side effects in
Reported by a pharmacist from United States on 2012-03-21
Patient:
Reactions: Fluid Overload, Chest Discomfort, Dyspnoea, Dilatation Ventricular, Condition Aggravated, Hyperdynamic Left Ventricle, Pericardial Effusion, Cardiomegaly, Death, Right Atrial Dilatation, Brain Natriuretic Peptide Increased, Oedema Peripheral, Oedema, Pulmonary Oedema, Pulmonary Artery Dilatation
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Epoprostenol Sodium
Dosage: 32 ng/kg, per min
Epoprostenol Sodium
Dosage: 39 ng/kg, per min
End date: 2012-03-12
Epoprostenol Sodium
Dosage: 29 ng/kg, per min
Indication: Pulmonary Arterial Hypertension
Start date: 2010-12-24
Letairis
Other drugs received by patient: Bumex; Midodrine Hydrochloride; Aranesp
Possible Letairis side effects in female
Reported by a consumer/non-health professional from United States on 2012-03-09
Patient: female
Reactions: Dyspnoea, Pulmonary Oedema, Pulmonary Function Test Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Dosage: 10 mg, unk
Administration route: Oral
Indication: Pulmonary Hypertension
Start date: 2011-03-20
Letairis
Dosage: unk
Administration route: Oral
Indication: Connective Tissue Disorder
Other drugs received by patient: Remodulin; Revatio
Possible Letairis side effects in 56 year old female
Reported by a consumer/non-health professional from United States on 2012-03-07
Patient: 56 year old female
Reactions: Pulmonary Oedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Other drugs received by patient: Revatio; Remodulin
Possible Letairis side effects in 56 year old female
Reported by a consumer/non-health professional from United States on 2012-02-28
Patient: 56 year old female
Reactions: Pulmonary Oedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Other drugs received by patient: Remodulin; Revatio
Possible Letairis side effects in 75 year old female
Reported by a pharmacist from United States on 2012-01-30
Patient: 75 year old female
Reactions: Swelling, Pulmonary Oedema, Oedema, Fluid Retention
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Letairis
Possible Letairis side effects in female
Reported by a consumer/non-health professional from United States on 2012-01-19
Patient: female
Reactions: Pulmonary Oedema, Pericardial Effusion
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Possible Letairis side effects in female
Reported by a physician from United States on 2011-12-19
Patient: female
Reactions: Pneumonia, Dyspnoea, Pulmonary Arterial Hypertension, Pulmonary Oedema, Oxygen Supplementation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Other drugs received by patient: Lasix; Oxygen; Iloprost; Sildenafil
Possible Letairis side effects in female
Reported by a pharmacist from United States on 2011-12-13
Patient: female
Reactions: Pneumonia, Dyspnoea, Pulmonary Oedema, Pulmonary Arterial Hypertension, Oxygen Supplementation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Other drugs received by patient: Sildenafil; Lasix; Iloprost; Oxygen
Page 1 Next >>
|
